Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis

Journal of Nutritional Biochemistry

Volumn 21, Issue 12, 2010, Pages 1200-1206

  Chung, Min Yu ^a   Yeung, Steven F ^a   Park, Hea Jin ^a   Volek, Jeff S ^a   Bruno, Richard S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Alanine aminotransferase; Inflammation; Lipid peroxidation; Nonalcoholic steatohepatitis; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; FATTY ACID; GAMMA TOCOPHEROL; LIPOPOLYSACCHARIDE; MALONALDEHYDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FOOD INTAKE; INFLAMMATION; LIPID PEROXIDATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ALANINE TRANSAMINASE; ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BODY WEIGHT; DIETARY SUPPLEMENTS; FATTY LIVER; GAMMA-TOCOPHEROL; INFLAMMATION; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, OBESE; OXIDATIVE STRESS; TRIGLYCERIDES;

MUS;

EID: 78249259701     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.10.006     Document Type: Article

References (45)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
3. Ayyad C., Andersen T. Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes Rev 2000, 1:113-119.
4. Portincasa P., Grattagliano I., Palmieri V.O., Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 2005, 38:203-217.
5. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
6. Carter-Kent C., Zein N.N., Feldstein A.E. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 2008, 103:1036-1042.
7. Diehl A.M. Lessons from animal models of NASH. Hepatol Res 2005.
8. Larter C.Z., Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 2008, 23:1635-1648.
9. Romics L., Kodys K., Dolganiuc A., Graham L., Velayudham A., Mandrekar P., et al. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Hepatology 2004, 40:376-385.
10. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997, 94:2557-2562.
11. Yang S., Lin H., Diehl A.M. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol 2001, 281:G382-G392.
12. Ozer J., Ratner M., Shaw M., Bailey W., Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008, 245:194-205.
13. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palu G., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G518-525.
14. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001, 48:206-211.
15. Bruno R.S., Traber M.G. Cigarette smoke alters human vitamin E requirements. J Nutr 2005, 135:671-674.
16. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000, 136:734-738.
17. Hasegawa T., Yoneda M., Nakamura K., Makino I., Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001, 15:1667-1672.
18. Kugelmas M., Hill D.B., Vivian B., Marsano L., McClain C.J. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003, 38:413-419.
19. Nobili V., Manco M., Devito R., Ciampalini P., Piemonte F., Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006, 24:1553-1561.
20. Nobili V., Manco M., Devito R., Di Ciommo V., Comparcola D., Sartorelli M.R., et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008, 48:119-128.
21. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., Ames B.N. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997, 94:3217-3222.
22. Leonard S.W., Bruno R.S., Paterson E., Schock B.C., Atkinson J., Bray T.M., et al. 5-nitro-gamma-tocopherol increases in human plasma exposed to cigarette smoke in vitro and in vivo. Free Radic Biol Med 2003, 35:1560-1567.
23. Jiang Q., Lykkesfeldt J., Shigenaga M.K., Shigeno E.T., Christen S., Ames B.N. Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic Biol Med 2002, 33:1534-1542.
24. Traber M.G., Siddens L.K., Leonard S.W., Schock B., Gohil K., Krueger S.K., et al. Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets. Free Radic Biol Med 2005, 38:773-785.
25. Bruno R.S., Dugan C.E., Smyth J.A., DiNatale D.A., Koo S.I. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 2008, 138:323-331.
26. Fiorini R.N., Donovan J.L., Rodwell D., Evans Z., Cheng G., May H.D., et al. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl 2005, 11:298-308.
27. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
28. Bella D.L., Schock B.C., Lim Y., Leonard S.W., Berry C., Cross C.E., et al. Regulation of the alpha-tocopherol transfer protein in mice: lack of response to dietary vitamin E or oxidative stress. Lipids 2006, 41:105-112.
29. Podda M., Weber C., Traber M.G., Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J Lipid Res 1996, 37:893-901.
30. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
31. Lykkesfeldt J. Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 2001, 47:1725-1727.
32. Thiele J.J., Traber M.G., Polefka T.G., Cross C.E., Packer L. Ozone-exposure depletes vitamin E and induces lipid peroxidation in murine stratum corneum. J Invest Dermatol 1997, 108:753-757.
33. Zhao J., Chen H., Li Y. Protective effect of bicyclol on acute alcohol-induced liver injury in mice. Eur J Pharmacol 2008, 586:322-331.
34. Boehm O., Zur B., Koch A., Tran N., Freyenhagen R., Hartmann M., et al. Clinical chemistry reference database for Wistar rats and C57/BL6 mice. Biol Chem 2007, 388:547-554.
35. Endo M., Masaki T., Seike M., Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 2007, 232:614-621.
36. Feingold K.R., Doerrler W., Dinarello C.A., Fiers W., Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992, 130:10-16.
37. Phung N., Pera N., Farrell G., Leclercq I., Hou J.Y., George J. Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis. Int J Mol Med 2009, 24:171-180.
38. Nan Y.M., Wu W.J., Fu N., Liang B.L., Wang R.Q., Li L.X., et al. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol 2009, 1-11.
39. Soden J.S., Devereaux M.W., Haas J.E., Gumpricht E., Dahl R., Gralla J., et al. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis. Hepatology 2007, 46:485-495.
40. Mustacich D.J., Gohil K., Bruno R.S., Yan M., Leonard S.W., Ho E., et al. Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice. J Nutr Biochem 2008.
41. Jiang Q., Ames B.N. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. Faseb J 2003, 17:816-822.
42. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 2000, 97:11494-11499.
43. Wiser J., Alexis N.E., Jiang Q., Wu W., Robinette C., Roubey R., et al. In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects. Free Radic Biol Med 2008, 45:40-49.
44. Suzuki A., Lymp J., Sauver J.S., Angulo P., Lindor K. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver Int 2006, 26:1209-1216.
45. Maras J.E., Bermudez O.I., Qiao N., Bakun P.J., Boody-Alter E.L., Tucker K.L. Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc 2004, 104:567-575.